Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Study Phase
Phase 3
Study Completion Date
September 2017
NCT00408005Uploaded 01-06-2021
Access via NCI by Request
PDS UID: nci-data-443
Intensified Methotrexate, Nelarabine (Compound 506U78) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma
Files: NCT00408005-D1
Data DictionaryNCT00408005-D1-Data-Dictionary_2.pdf
DATANCT00408005-D1-Dataset_3.csv
OTHERREADME.pdf
Files: NCT00408005-D2
Data DictionaryNCT00408005-D2-Data-Dictionary_2.pdf
DATANCT00408005-D2-Dataset_2.csv
OTHERREADME.pdf